Capital Group Gets Biggest Stake in Bayer
August 31, 2005Advertisement
US investment fund Capital Group Companies has become the largest single shareholder in German chemicals and pharmaceuticals giant Bayer, Bayer revealed in a mandatory legal filing published in the German press on Wednesday. Capital Group's shareholding in the German maker of Aspirin rose above the key threshold of 5 percent to 5.037 percent on August 18, Bayer said in a statement published in the financial daily Börsen-Zeitung. And on its Web site, Bayer said that "we are aware of no other single shareholder that holds more than 5 percent." Data published by the German stock exchange showed that all of Bayer's capital had been in free float at the end of June.